Specific Consequences of the GSK Continue Option. If GSK terminates this Agreement or a Program under Sections 14.3, 14.4 or 14.5, the rights and obligations of the Parties hereunder shall terminate as at the effective date of such termination (or, if later, the Cut-Over Date) and the consequences set forth in this Section 15 shall apply:
Appears in 3 contracts
Samples: Fourth Amendment and Restatement Agreement (CureVac N.V.), 2020 Cla Amendment and Restatement Agreement (CureVac N.V.), Collaboration and License Agreement (CureVac B.V.)
Specific Consequences of the GSK Continue Option. If GSK terminates this Agreement or a Program under Sections 14.314.4, 14.4 14.5 or 14.514.6, the rights and obligations of the Parties hereunder shall terminate as at the effective date of such termination (or, if later, the Cut-Over Date) and the consequences set forth in this Section 15 15.6 shall apply:
Appears in 2 contracts
Samples: Covid Collaboration and License Agreement, Covid Collaboration and License Agreement (CureVac N.V.)
Specific Consequences of the GSK Continue Option. If GSK terminates this Agreement or a Program under Sections 14.314.4, 14.4 14.5 or 14.514.6, the rights and obligations of the Parties hereunder shall terminate as at the effective date of such termination (or, if later, the Cut-Over Date) and and, subject to Section 15.4, the consequences set forth in this Section 15 15.6 shall apply:
Appears in 1 contract
Samples: Covid Cla Third Amendment and Restatement Agreement (CureVac N.V.)
Specific Consequences of the GSK Continue Option. β If GSK terminates this Agreement or a Program under Sections 14.314.4, 14.4 14.5 or 14.514.6, the rights and obligations of the Parties hereunder shall terminate as at the effective date of such termination (or, if later, the Cut-Over Date) and the consequences set forth in this Section 15 15.6 shall apply:: β
Appears in 1 contract
Samples: Covid Cla Amendment and Restatement Agreement (CureVac N.V.)
